Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-421 plus Chidamide for HIV-1 Reservoir Reduction
NCT05056974Phase 2Completed
- Sponsor
- United BioPharma
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of semzuvolimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by United BioPharma. Started Dec 2021; status: completed.
02
Drugs
semzuvolimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT05056974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05056974.